• / Free eNewsletters & Magazine
  • / My Account
Home>Regions>United Kingdom

United Kingdom

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Non-Life Insurance Investments in the United Kingdom to 2019: Market Databook - Research and Markets

    Non-Life Insurance Investments in the United Kingdom to 2019: Market Databook - Research and Markets

  2. CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U .K .

    CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U . K .

  3. Sopra Steria Group: Weekly Disclosure of Transactions in Own Shares for the Month of February 2017

    Sopra Steria Group: Weekly Disclosure of Transactions in Own Shares for the Month of February 2017

  4. Theresa May to Meet Peugeot CEO Amid Concerns Over Vauxhall

    Theresa May to Meet Peugeot CEO Amid Concerns Over Vauxhall

  5. Theresa May to Meet Peugeot CEO Amid Concerns Over Vauxhall -- Update

    Theresa May to Meet Peugeot CEO Amid Concerns Over Vauxhall -- Update

  6. UPDATE: Theresa May expected to air concerns over Vauxhall bid with Peugeot CEO

    UPDATE: Theresa May expected to air concerns over Vauxhall bid with Peugeot CEO

  7. Kraft Withdraws $143 Billion Offer for Unilever -- 3rd Update

    Kraft Withdraws $143 Billion Offer for Unilever -- 3rd Update

  8. Kraft's Unilever Bid Could Face Two Sides of Regulatory Coin -- 2nd Update

    Kraft's Unilever Bid Could Face Two Sides of Regulatory Coin -- 2nd Update

  9. Unilever Chief Raises the Defenses as Kraft Heinz Circles

    Unilever Chief Raises the Defenses as Kraft Heinz Circles

  10. EUROPE MARKETS: European Stocks End Higher, Led By RBS, Rolls-Royce

    EUROPE MARKETS: European Stocks End Higher, Led By RBS, Rolls-Royce

12345

©2017 Morningstar Advisor. All right reserved.